Engineering deep dive outlines how disabling UCX mmap hooks stopped runaway RSS in disaggregated serving on 21 January 2026.

Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...

The "Lazarus" stock: Here’s why Imperial Metals (TSX:III) stock rose 450% from the ashes in 2025 The post Meet the Canadian ...

Historically, most companies have focused their time, energy and resources on their bottom lines and securing the best financial performance for their shareholders. But times are changing and people ...